← FDA Drug Approvals (Drugs@FDA)

ENZALUTAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2024-09-26

Drug application

FDA Application #

ANDA209667

Application type

Abbreviated New Drug Application (Generic)

Brand name

ENZALUTAMIDE

Generic name

Enzalutamide

Active ingredients

ENZALUTAMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ZYDUS PHARMS

First approval

2024-09-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown